Biocryst Pharmaceuticals (BCRX) Net Shares Issued and Repurchased (2011 - 2022)

Biocryst Pharmaceuticals (BCRX) has reported Net Shares Issued and Repurchased for 12 consecutive years, with $369000.0 the latest figure, recorded in Q1 2022.

• For the quarter ending Q1 2022, Net Shares Issued and Repurchased rose 846.15% year-over-year to $369000.0; the trailing twelve-month figure through Mar 2022 stood at $369000.0 (up 846.15% YoY), and the FY2021 full-year result was $7.8 million, down 25.93% from the prior year.
• Net Shares Issued and Repurchased retreated to $369000.0 in Q1 2022 per BCRX's latest filing, from $7.8 million in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $10.5 million in Q4 2020 and bottomed at $39000.0 in Q1 2021.
• Historically, Net Shares Issued and Repurchased has averaged $2.8 million across 5 years, with a median of $369000.0 in 2022.
• The sharpest annual moves came in 2020 and 2021: Net Shares Issued and Repurchased jumped 3224.13% in 2020, then slumped 97.88% in 2021.
• Over 5 years, Net Shares Issued and Repurchased stood at $4.3 million in 2018, then slumped by 92.63% to $315000.0 in 2019, then surged by 3224.13% to $10.5 million in 2020, then retreated by 25.93% to $7.8 million in 2021, then plunged by 95.24% to $369000.0 in 2022.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $369000.0, $7.8 million, and $39000.0 for Q1 2022, Q4 2021, and Q1 2021 respectively.